Stroke Trial, Recruiting (NCT06213272)

Stroke Trial, Recruiting NCT06213272 Sponsor: Kessler Foundation Condition: Stroke

Printed from Voxsanity (voxsanity.com.au) — NCT06213272 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stroke

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who were fluent and able to read in English before their stroke
People who have had their first-ever stroke
People who are more than 3 months past their stroke
People who have difficulty reading after their stroke, based on specific accuracy scores for reading words or non-words aloud
People who live within 50 miles of Kessler Foundation

Who may not be able to join:

People for whom an MRI scan would not be safe (confirm with trial site)
People who have had a previous neurological condition or brain disease before their stroke
People who had a developmental learning or reading disability (such as dyslexia) before their stroke
People for whom exercise would not be medically safe (confirm with trial site)
People who are currently receiving speech and language therapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 6 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Olga Boukrina, Kessler Foundation

Phone: 19733243587

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06213272

Sponsor: Kessler Foundation

Phase: Not Applicable

Status: Recruiting

Condition: Stroke

Trial contact: 19733243587

More information: https://clinicaltrials.gov/study/NCT06213272

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who were fluent and able to read in English before their stroke
People who have had their first-ever stroke
People who are more than 3 months past their stroke
People who have difficulty reading after their stroke, based on specific accuracy scores for reading words or non-words aloud
People who live within 50 miles of Kessler Foundation

Who may not be able to join:

People for whom an MRI scan would not be safe (confirm with trial site)
People who have had a previous neurological condition or brain disease before their stroke
People who had a developmental learning or reading disability (such as dyslexia) before their stroke
People for whom exercise would not be medically safe (confirm with trial site)
People who are currently receiving speech and language therapy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 6 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Kessler Foundation

Registry

ClinicalTrials.gov

Start date

18 April 2024

Est. completion

1 March 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Reading Aloud; 2 Alternative Forced Choice Computer Tasks; Reading Comprehension Battery for Aphasia - 2nd edition (RCBA-2); Cerebral Blood Flow (CBF); Resting State Functional Connectivity (rsFC); Task-induced fMRI activation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov